Roy, Akanksha
Tolone, Arianna
Hilhorst, Riet http://orcid.org/0000-0002-8261-1299
Groten, John
Tomar, Tushar http://orcid.org/0000-0002-3344-7605
Paquet-Durand, François http://orcid.org/0000-0001-7355-5742
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (765441, 765441, 765441, 765441, 765441)
Article History
Received: 20 October 2021
Revised: 16 December 2021
Accepted: 8 February 2022
First Online: 3 March 2022
Competing interests
: AR, TT, RH, JG are current or former employees of PamGene International B.V., ‘s-Hertogenbosch, The Netherlands. FPD is shareholder of the company Mireca Medicines, Tübingen, Germany, which intends to forward clinical testing of CN03.